Skip to main content
Fig. 10 | Acta Neuropathologica Communications

Fig. 10

From: Stem cell phenotype predicts therapeutic response in glioblastomas with MGMT promoter methylation

Fig. 10

Kaplan–Meier survival curves for patients with GBM stratified by high or low SOX2 (separated at the median level) and MGMT methylation status. The high SOX2/methylated group has the longest survival of the four groups (upper panel). Kaplan–Meier survival curves for patients with GBM comparing high SOX2/methylated patients to all other groups combined (lower panel)

Back to article page